489 related articles for article (PubMed ID: 11158813)
1. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA;
Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813
[TBL] [Abstract][Full Text] [Related]
2. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2020 Apr; 127(4S):S148-S157. PubMed ID: 32200815
[TBL] [Abstract][Full Text] [Related]
3. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159
[TBL] [Abstract][Full Text] [Related]
4. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
[TBL] [Abstract][Full Text] [Related]
5. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM;
Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
[TBL] [Abstract][Full Text] [Related]
7. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.
Diener-West M; Earle JD; Fine SL; Hawkins BS; Moy CS; Reynolds SM; Schachat AP; Straatsma BR;
Arch Ophthalmol; 2001 Jul; 119(7):951-65. PubMed ID: 11448318
[TBL] [Abstract][Full Text] [Related]
8. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS report no. 9.
Am J Ophthalmol; 1998 Jun; 125(6):767-78. PubMed ID: 9645715
[TBL] [Abstract][Full Text] [Related]
9. I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30.
Boldt HC; Melia BM; Liu JC; Reynolds SM;
Ophthalmology; 2009 Jan; 116(1):106-115.e1. PubMed ID: 19118701
[TBL] [Abstract][Full Text] [Related]
10. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
[TBL] [Abstract][Full Text] [Related]
11. Plaque radiotherapy for choroidal melanoma encircling the optic disc (circumpapillary choroidal melanoma).
Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
Arch Ophthalmol; 2007 Sep; 125(9):1202-9. PubMed ID: 17846359
[TBL] [Abstract][Full Text] [Related]
12. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
[TBL] [Abstract][Full Text] [Related]
13. Baseline echographic characteristics of tumors in eyes of patients enrolled in the Collaborative Ocular Melanoma Study: COMS report no. 29.
; Boldt HC; Byrne SF; Gilson MM; Finger PT; Green RL; Straatsma BR; Simpson ER; Hawkins BS
Ophthalmology; 2008 Aug; 115(8):1390-7, 1397.e1-2. PubMed ID: 18267342
[TBL] [Abstract][Full Text] [Related]
14. Visual acuity, oncologic, and toxicity outcomes with
Patel KR; Prabhu RS; Switchenko JM; Chowdhary M; Craven C; Mendoza P; Danish H; Grossniklaus HE; Aaberg TM; Aaberg T; Reddy S; Butker E; Bergstrom C; Crocker IR
Brachytherapy; 2017; 16(3):646-653. PubMed ID: 28262517
[TBL] [Abstract][Full Text] [Related]
15. Factors predictive of growth and treatment of small choroidal melanoma: COMS Report No. 5. The Collaborative Ocular Melanoma Study Group.
Arch Ophthalmol; 1997 Dec; 115(12):1537-44. PubMed ID: 9400787
[TBL] [Abstract][Full Text] [Related]
16. Assessment of central vision and macular structure in patients undergoing iodine-125 brachytherapy for ciliochoroidal melanoma.
Oliver SC; Young TA; Kobe LH; Leu MY; Lee SP; Chun MW; Straatsma BR
Am J Clin Oncol; 2008 Oct; 31(5):488-92. PubMed ID: 18838887
[TBL] [Abstract][Full Text] [Related]
17. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.
Diener-West M; Earle JD; Fine SL; Hawkins BS; Moy CS; Reynolds SM; Schachat AP; Straatsma BR;
Arch Ophthalmol; 2001 Jul; 119(7):969-82. PubMed ID: 11448319
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
[TBL] [Abstract][Full Text] [Related]
19. Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects.
Jones R; Gore E; Mieler W; Murray K; Gillin M; Albano K; Erickson B
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):989-95. PubMed ID: 11958893
[TBL] [Abstract][Full Text] [Related]
20. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.
Collaborative Ocular Melanoma Study Group
Arch Ophthalmol; 2006 Dec; 124(12):1684-93. PubMed ID: 17159027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
